PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
PDS Biotechnology (PDSB) Misses Q1 EPS by 10c
May 11, 2022 7:16 AM EDTPDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.32), $0.10 worse than the analyst estimate of ($0.22).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
... More